Quest Capital Management’s GSK GSK Stock Holding History

Quest Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$559K	Hold	10,142	–	–	0.1%	136
2021 Q3	$484K	Hold	10,142	–	–	0.1%	140
2021 Q2	$505K	Sell	10,142 -51	-0.5%	-$2.45K	0.1%	135
2021 Q1	$455K	Buy	10,193 +1,901	+23%	+$86.3K	0.1%	129
2020 Q4	$381K	Sell	8,292 -518	-6%	-$23.8K	0.09%	142
2020 Q3	$415K	Sell	8,810 -417	-5%	-$20.9K	0.11%	114
2020 Q2	$470K	Sell	9,227 -315	-3%	-$16.2K	0.14%	94
2020 Q1	$452K	Sell	9,542 -1,219	-11%	-$65K	0.16%	82
2019 Q4	$632K	Sell	10,761 -376	-3%	-$20.9K	0.15%	84
2019 Q3	$594K	Sell	11,137 -992	-8%	-$51K	0.15%	91
2019 Q2	$607K	Sell	12,129 -1,694	-12%	-$85K	0.15%	81
2019 Q1	$721K	Buy	+13,823	New	+$691K	0.18%	78

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Quest Capital Management's GSK Position: Q4 2021 in Review

Quest Capital Management held its GSK (GSK) position steady in Q4 2021 at 10,142 shares worth $559K. The position accounts for 0.1% of the portfolio, ranked #136.

Quest Capital Management first reported a position in GSK in Q1 2019 and has held it in 12 quarters since. The position peaked at $721K in Q1 2019. 919 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

Quest Capital Management held 10,142 shares of GSK worth $559K as of Q4 2021.
Quest Capital Management left its GSK share count unchanged in Q4 2021.
GSK made up 0.1% of Quest Capital Management's portfolio in Q4 2021, its #136 holding.
Quest Capital Management first reported a position in GSK in Q1 2019 and has held it in 12 quarters since.
Quest Capital Management's GSK position peaked at $721K in Q1 2019.
919 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on Quest Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.